Confetti-like macular atrophy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:221142L90.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Confetti-like macular atrophy is an extremely rare skin condition that falls under the broader category of atrophic skin disorders. In this condition, small, scattered, pale or white spots develop on the skin, resembling confetti sprinkled across the affected areas. These spots represent areas where the skin has become thinner (atrophied) and lost its normal pigmentation. The condition primarily affects the appearance of the skin and is classified under "other atrophic disorders of skin" in medical coding systems. Because this condition is so rare, detailed information about its exact cause, progression, and optimal treatment is limited. The spots are typically small, well-defined, and may appear on various parts of the body. They are usually painless but can be cosmetically concerning for patients. The condition may be confused with other disorders that cause white spots or skin thinning, such as idiopathic guttate hypomelanosis or other forms of macular atrophy. Currently, there is no specific cure for confetti-like macular atrophy. Treatment is generally focused on managing the cosmetic appearance and protecting the affected skin. Patients are typically followed by dermatologists who can monitor the condition over time and help distinguish it from other similar-looking skin disorders. Sun protection is generally recommended for affected areas, as atrophic skin may be more vulnerable to sun damage.

Key symptoms:

Small white or pale spots on the skinThinning of the skin in affected areasConfetti-like pattern of skin color lossSmooth, flat spots that may feel thinner than surrounding skinCosmetic changes to skin appearancePossible increased fragility of affected skin areas

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Confetti-like macular atrophy.

View clinical trials →

No actively recruiting trials found for Confetti-like macular atrophy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Confetti-like macular atrophy community →

No specialists are currently listed for Confetti-like macular atrophy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Confetti-like macular atrophy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Confetti-like macular atrophyForum →

No community posts yet. Be the first to share your experience with Confetti-like macular atrophy.

Start the conversation →

Latest news about Confetti-like macular atrophy

No recent news articles for Confetti-like macular atrophy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the likely cause of these spots on my skin?,How can we be sure this is confetti-like macular atrophy and not another condition?,Will the spots continue to spread or get worse over time?,Are there any treatments that can help reduce the appearance of the spots?,Should I take any special precautions to protect my skin?,Is there any genetic testing that would be helpful for my family?,Are there any clinical trials or new research for this condition?

Common questions about Confetti-like macular atrophy

What is Confetti-like macular atrophy?

Confetti-like macular atrophy is an extremely rare skin condition that falls under the broader category of atrophic skin disorders. In this condition, small, scattered, pale or white spots develop on the skin, resembling confetti sprinkled across the affected areas. These spots represent areas where the skin has become thinner (atrophied) and lost its normal pigmentation. The condition primarily affects the appearance of the skin and is classified under "other atrophic disorders of skin" in medical coding systems. Because this condition is so rare, detailed information about its exact cause,

How is Confetti-like macular atrophy inherited?

Confetti-like macular atrophy follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Confetti-like macular atrophy typically begin?

Typical onset of Confetti-like macular atrophy is adult. Age of onset can vary across affected individuals.